Results 231 to 240 of about 549,826 (262)

PD‐1/PD‐L1 in Hepatocellular Carcinoma (2014–2024): A Combined Macro and Micro Analysis of Immunotherapy Implications

open access: yesiNew Medicine, EarlyView.
ABSTRACT Hepatocellular carcinoma (HCC) represents a significant global health issue, with the PD‐1/PD‐L1 axis serving a pivotal target for immunotherapy in this malignancy. However, a comprehensive bibliometric analysis of PD‐1/PD‐L1 research in HCC is lacking.
Xingyu Zhu   +4 more
wiley   +1 more source

IL-21 attenuates liver inflammation by enhancing myeloid-derived suppressor cells immunosuppressive function in chronic HBV infection. [PDF]

open access: yesJ Transl Med
Li X   +12 more
europepmc   +1 more source

The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birth. [PDF]

open access: yesHum Vaccin Immunother
Van Damme P   +26 more
europepmc   +1 more source

Higher risk of postpartum phase transition to immune-active among HBeAg-positive pregnant women with indeterminate phase. [PDF]

open access: yesFront Cell Infect Microbiol
Tang Q   +9 more
europepmc   +1 more source

Viral Hepatitis Surveillance in the United States: Then, Now, and Looking Forward. [PDF]

open access: yesPublic Health Rep
Jiles RB   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy